Elicera Therapeutics Names Johan Liwing as CEO

Company: Elicera Therapeutics · Event Type: CEO Succession · Effective Date: September 1, 2026 · Predecessor: Jamal El-Mosleh (Co-Founder) · Announcement Date: August 18, 2026 Summary Elicera Therapeutics appointed Johan Liwing as chief executive officer effective September 1, 2026. He succeeds co-founder Jamal El-Mosleh, who…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Astellas / AviadoBio – Gene Therapy Program Sustained via Nonprofit Funding
Samsung Biologics Moves Into Peptide Manufacturing
Boulevard Bio Launches with $65 Million
GSK – $1B SiranBio Oligo Deal